市場調査レポート

商品コード

テレヘルス&遠隔医療の世界市場 (～2030年)：機能 (遠隔診察・RPM・診断&治療・分析・事務)・用途 (遠隔lCU・遠隔放射線・遠隔循環器・糖尿病)・エンドユーザー (病院・ASC・保険者)・地域別

Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030

出版日: 2025年02月03日
発行: MarketsandMarkets
ページ情報: 英文 501 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 4,950 726,759円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (5-user License)

USD 6,650 976,353円

レポートPDFを同じ国内の同じ事業所内の5名迄にて共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate License)

USD 8,150 1,196,583円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありませんが、同一国内にある事業所のみとなり、海外支店などは含まれません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global License)

USD 10,000 1,468,200円

レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。100％子会社は同一企業とみなされます。PDF内のテキスト等のコピー＆ペースト可能です。PDの印刷は何回でも可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

テレヘルス&遠隔医療の市場規模は、2024年の941億4,000万米ドルから、2024年から2030年にかけてはCAGR 11.5%で推移し、2030年には1,808億6,000万米ドルの規模に成長すると予測されています。

通信技術の進歩、政府の支援や規制政策、遠隔患者モニタリングシステムの拡大など様々な要因により、テレヘルス&遠隔医療の市場は急速に拡大しています。高齢化により慢性疾患の継続的なモニタリングが必要となり、費用対効果の高いヘルスケアソリューションへの需要が高まっています。さらに、糖尿病や心血管疾患などの慢性疾患の有病率が上昇していることも、遠隔診療の価値を強調しています。遠隔医療は多くの時間と費用を節約できるため、患者と医療提供者の双方にとって魅力的なものとなっています。遠隔での患者モニタリング技術の採用の増加や、通信技術の進歩がバーチャルケアの成功率と市場導入を高めており、有利な規制や償還可能な枠組みを通じた政府の支援も市場拡大に貢献しています。

調査範囲
調査対象年	2024-2030年
基準年	2023年
予測期間	2024-2030年
単位	金額 (米ドル)
セグメント	コンポーネント・機能・用途・年齢層・エンドユーザー・地域
対象地域	北米・欧州・アジア太平洋・ラテンアメリカ・中東アフリカ

”エンドユーザー別では、患者部門が予測期間中に最大の成長を示す見通し"

これは主に、患者が自宅に居ながらにして診察や治療を受けることができる遠隔ヘルスケアサービスの導入が拡大しているためです。また、慢性疾患の増加、便利でタイムリーな医療へのニーズ、遠隔医療の利点に対する意識の高まりなども成長の要因に挙げられます。COVID-19の大流行も遠隔医療を加速させ、患者は対面診療に代わるより安全な方法を求めています。患者の快適性の向上、ヘルスケアコストの削減、特に地方やサービスが行き届いていない地域における専門医へのアクセスの改善なども成長推進因子として挙げられます。

"コンポーネント別では、ソフトウェア部門が最大のシェアを示す"

これは、仮想診察、遠隔患者モニタリング、電子カルテ管理のための遠隔医療プラットフォーム利用の増加によるものです。ヘルスケアプロバイダーによるデジタルリソースの利用が、効率的な方法でケアを提供するために広まりつつあり、ビデオ会議、予約スケジューリング、安全なメッセージング、データ分析のためのソフトウェアが急速に重要になってきています。遠隔医療アプリケーションソフトウェアにAIと機械学習が統合されたことで、診断能力の強化、患者に合わせた臨床管理、より良い転帰が提供され、市場の拡大が加速しています。さらに、ヘルスケアシステム間のシームレスな相互運用性と、データセキュリティとプライバシーのための規制遵守への注目の高まりも、高度な遠隔医療ソフトウェアの需要をさらに加速させています。

"アジア太平洋地域が予測期間中に最大のCAGRを記録する見通し"

アジア太平洋地域は、急速に開発されているヘルスケアインフラ、デジタル技術の進歩の恩恵を受けています。これは、デジタルヘルスケア製品の使用の増加、人口の増加と高齢化に起因するヘルスケアニーズ、慢性疾患の罹患率の増加などの複数の要因によるものです。さらに、インドや中国などの地域では、インターネットの普及やモバイルの普及が進み、遠隔医療サービスの成長が加速しています。遠隔医療を推進する政府の活動やデジタル医療インフラの改善も同市場の成長に寄与する役割を果たしています。

当レポートでは、世界のテレヘルス&遠隔医療の市場を調査し、市場概要、市場成長への各種影響因子の分析、技術・特許の動向、法規制環境、ケーススタディ、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

市場力学
- 促進要因
- 抑制要因
- 機会
- 課題
顧客の事業に影響を与える動向/ディスラプション
業界動向
エコシステム分析
バリューチェーン分析
技術分析
関税と規制の分析
貿易分析
価格分析
ポーターのファイブフォース分析
主なステークホルダーと購入基準
特許分析
アンメットニーズとエンドユーザーの期待
主な会議とイベント
ケーススタディ分析
投資と資金調達のシナリオ
ビジネスモデル分析
テレヘルス&遠隔医療市場におけるAI/生成AIの影響
償還シナリオ分析

第6章テレヘルス&遠隔医療市場：コンポーネント別

ハードウェア
- 遠隔医療キット、カート、ステーション
- 患者モニタリングデバイス
ソフトウェア
- モダリティ別
- 統合タイプ別
- タイプ別
- 導入別
サービス

第7章テレヘルス&遠隔医療市場：機能別

臨床ケア管理
予防ケア管理
診断・治療
遠隔患者モニタリング/患者モニタリング
リハビリテーション・回復
事務
分析・報告
患者エンゲージメント
その他

第8章テレヘルス&遠隔医療市場：用途別

プライマリケア
専門ケア
- 遠隔放射線
- 遠隔循環器診療
- 遠隔神経内科診療
- 糖尿病
- 呼吸器疾患
- 高血圧
- 遠隔皮膚科診療
- 遠隔脳卒中診療
- 遠隔精神科診療
- その他
遠隔ICU
バーチャルケア
その他

第9章テレヘルス&遠隔医療市場：年齢層別

小児
大人
老年医学

第10章テレヘルス&遠隔医療市場：エンドユーザー別

ヘルスケア提供者
- 病院
- 外来手術センター、外来ケアセンター、その他の外来診療施設
- 長期介護および生活支援施設
- ホームヘルスケア
- その他
ヘルスケア保険者
- 公的保険者
- 民間保険者
患者
製薬・バイオテクノロジー企業
医療技術企業
その他

第11章テレヘルス&遠隔医療市場：地域別

北米
- マクロ経済見通し
- 米国
- カナダ
欧州
- マクロ経済見通し
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他
アジア太平洋
- マクロ経済見通し
- 中国
- 日本
- インド
- オーストラリア
- その他
ラテンアメリカ
- マクロ経済見通し
- ブラジル
- メキシコ
- その他
中東・アフリカ
- マクロ経済見通し
- GCC諸国
- その他

第12章競合情勢

主要参入企業の戦略/強み
収益分析
市場シェア分
企業評価マトリックス：主要企業
企業評価マトリックス：スタートアップ/中小企業
企業評価と財務指標
ブランド/ソフトウェア比較分析
競合シナリオ

第13章企業プロファイル

主要企業
- MEDTRONIC
- TELADOC HEALTH, INC.
- CISCO SYSTEMS, INC.
- KONINKLIJKE PHILIPS N.V.
- ZOOM COMMUNICATIONS, INC.
- GE HEALTHCARE
- EPIC SYSTEMS CORPORATION
- ORACLE
- DOXIMITY, INC.
- AMERICAN WELL
- SIEMENS HEALTHINEERS AG
- INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.)
- AMC HEALTH
- TELESPECIALISTS
- WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
- CAREGILITY
- CVS HEALTH
- EVERNORTH HEALTH, INC.
- ELATION
- IRON BOW TECHNOLOGIES
その他の企業
- TIMEDOC, INC.
- CEREBRAL INC.
- KINDBODY
- TRANSCARENT
- CARESIMPLE INC.

第14章付録

図表

List of Tables

TABLE 1 TELEHEALTH & TELEMEDICINE MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 TELEHEALTH & TELEMEDICINE MARKET: STUDY ASSUMPTIONS
TABLE 3 TELEHEALTH & TELEMEDICINE MARKET: RISK ASSESSMENT
TABLE 4 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 5 CHRONIC DISEASES AND RELATED COST BURDEN IN US
TABLE 6 RECENT DEVELOPMENTS IN REMOTE PATIENT MONITORING SYSTEMS, JANUARY 2023-JANUARY 2025
TABLE 7 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH
TABLE 8 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011-2024
TABLE 9 INDUSTRY TRENDS IN TELEHEALTH & TELEMEDICINE MARKET
TABLE 10 OVERVIEW OF TELEHEALTH USE CASES
TABLE 11 TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM
TABLE 12 AVERAGE TARIFF FOR HS CODE 9018, 2023
TABLE 13 AVERAGE TARIFF FOR HS CODE 9021, 2023
TABLE 14 AVERAGE TARIFF FOR HS CODE 9022, 2023
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS
TABLE 19 REGULATORY REQUIREMENTS IN NORTH AMERICA
TABLE 20 REGULATORY REQUIREMENTS IN EUROPE
TABLE 21 REGULATORY REQUIREMENTS IN ASIA PACIFIC
TABLE 22 REGULATORY REQUIREMENTS IN LATIN AMERICA
TABLE 23 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA
TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 26 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 27 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 28 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 29 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 30 COST RANGE INVOLVED IN TELEMEDICINE DEVICES (USD)
TABLE 31 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS, BY COMPONENT, 2023
TABLE 32 AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS, 2023
TABLE 33 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2023
TABLE 34 TELEHEALTH & TELEMEDICINE MARKET: PORTER'S FIVE FORCES
TABLE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY TYPE
TABLE 36 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS
TABLE 37 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR TELEHEALTH & TELEHEALTH
TABLE 38 UNMET NEEDS IN TELEHEALTH & TELEMEDICINE MARKET
TABLE 39 END-USER EXPECTATIONS IN TELEHEALTH & TELEMEDICINE MARKET
TABLE 40 TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
TABLE 41 CASE 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA'S INTEGRATED SOLUTIONS
TABLE 42 CASE 2: USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES
TABLE 43 CASE 3: CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS
TABLE 44 AI TO REDEFINE TREATMENT EFFECTIVENESS AND SAFETY
TABLE 45 AI-DRIVEN CHATBOTS AND TELEHEALTH TO ENHANCE MENTAL HEALTH AND CHRONIC DISEASE MANAGEMENT
TABLE 46 TELEHEALTH & TELEMEDICINE MARKET: CPT CODES AND REIMBURSEMENT ANALYSIS
TABLE 47 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 48 TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 49 TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 50 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR TELEHEALTH KITS, CARTS, AND STATIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 51 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 52 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 53 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (THOUSANDS UNITS)
TABLE 54 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 55 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 56 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 57 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 58 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 59 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 60 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 61 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PULSE OXIMETER DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 62 TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR OTHER PATIENT MONITORING DEVICES, BY REGION, 2022-2030 (USD MILLION)
TABLE 63 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 64 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 65 TELEHEALTH & TELEMEDICINE EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 66 TELEHEALTH & TELEMEDICINE NON-EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 67 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 68 TELEHEALTH & TELEMEDICINE INTEGRATED SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 69 TELEHEALTH & TELEMEDICINE STANDALONE SOFTWARE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 70 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 71 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR REMOTE PATIENT MONITORING PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
TABLE 72 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIRTUAL CARE PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
TABLE 73 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIDEO CONFERENCING PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
TABLE 74 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR VIRTUAL SITTING & NURSING PLATFORMS, BY REGION, 2022-2030 (USD MILLION)
TABLE 75 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 76 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT MODELS, BY REGION, 2022-2030 (USD MILLION)
TABLE 77 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT MODELS, BY REGION, 2022-2030 (USD MILLION)
TABLE 78 TELEHEALTH & TELEMEDICINE SERVICES MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 79 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 80 TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL CARE MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 81 TELEHEALTH & TELEMEDICINE MARKET FOR PREVENTIVE CARE MANAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 82 TELEHEALTH & TELEMEDICINE MARKET FOR DIAGNOSTICS & TREATMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 83 TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING/ PATIENT MONITORING, BY REGION, 2022-2030 (USD MILLION)
TABLE 84 TELEHEALTH & TELEMEDICINE MARKET FOR REHABILITATION & RECOVERY, BY REGION, 2022-2030 (USD MILLION)
TABLE 85 TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE, BY REGION, 2022-2030 (USD MILLION)
TABLE 86 TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING, BY REGION, 2022-2030 (USD MILLION)
TABLE 87 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT, BY REGION, 2022-2030 (USD MILLION)
TABLE 88 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 89 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 90 TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE, BY REGION, 2022-2030 (USD MILLION)
TABLE 91 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 92 TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY REGION, 2022-2030 (USD MILLION)
TABLE 93 TELEHEALTH & TELEMEDICINE MARKET FOR TELERADIOLOGY, BY REGION, 2022-2030 (USD MILLION)
TABLE 94 TELEHEALTH & TELEMEDICINE MARKET FOR TELECARDIOLOGY, BY REGION, 2022-2030 (USD MILLION)
TABLE 95 TELEHEALTH & TELEMEDICINE MARKET FOR TELENEUROLOGY, BY REGION, 2022-2030 (USD MILLION)
TABLE 96 TELEHEALTH & TELEMEDICINE MARKET FOR DIABETES, BY REGION, 2022-2030 (USD MILLION)
TABLE 97 TELEHEALTH & TELEMEDICINE MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 98 TELEHEALTH & TELEMEDICINE MARKET FOR HYPERTENSION, BY REGION, 2022-2030 (USD MILLION)
TABLE 99 TELEHEALTH & TELEMEDICINE MARKET FOR TELEDERMATOLOGY, BY REGION, 2022-2030 (USD MILLION)
TABLE 100 TELEHEALTH & TELEMEDICINE MARKET FOR TELESTROKE, BY REGION, 2022-2030 (USD MILLION)
TABLE 101 TELEHEALTH & TELEMEDICINE MARKET FOR TELEPSYCHIATRY, BY REGION, 2022-2030 (USD MILLION)
TABLE 102 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER SPECIALTY CARE APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 103 TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION, 2022-2030 (USD MILLION)
TABLE 104 TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL SITTING & NURSING, BY REGION, 2022-2030 (USD MILLION)
TABLE 105 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2030 (USD MILLION)
TABLE 106 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 107 TELEHEALTH & TELEMEDICINE MARKET FOR PEDIATRICS, BY REGION, 2022-2030 (USD MILLION)
TABLE 108 TELEHEALTH & TELEMEDICINE MARKET FOR ADULTS, BY REGION, 2022-2030 (USD MILLION)
TABLE 109 TELEHEALTH & TELEMEDICINE MARKET FOR GERIATRICS, BY REGION, 2022-2030 (USD MILLION)
TABLE 110 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 111 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 112 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 113 TELEHEALTH & TELEMEDICINE MARKET FOR HOSPITALS, BY REGION, 2022-2030 (USD MILLION)
TABLE 114 TELEHEALTH & TELEMEDICINE MARKET FOR AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022-2030 (USD MILLION)
TABLE 115 TELEHEALTH & TELEMEDICINE MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022-2030 (USD MILLION)
TABLE 116 TELEHEALTH & TELEMEDICINE MARKET FOR HOME HEALTHCARE, BY REGION, 2022-2030 (USD MILLION)
TABLE 117 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 118 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 119 TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 120 TELEHEALTH & TELEMEDICINE MARKET FOR PUBLIC HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 121 TELEHEALTH & TELEMEDICINE MARKET FOR PRIVATE HEALTHCARE PAYERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 122 TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION, 2022-2030 (USD MILLION)
TABLE 123 TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2030 (USD MILLION)
TABLE 124 TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES, BY REGION, 2022-2030 (USD MILLION)
TABLE 125 TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2022-2030 (USD MILLION)
TABLE 126 TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 127 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 128 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 129 NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 130 NORTH AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 131 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 132 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 133 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 134 NORTH AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 135 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 136 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 137 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 138 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 139 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 140 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 141 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 142 US: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 143 US: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 144 US: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 145 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 146 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 147 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 148 US: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 149 US: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 150 US: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 151 US: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 152 US: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 153 US: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 154 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 155 US: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 156 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 157 CANADA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 158 CANADA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 159 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 160 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 161 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 162 CANADA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 163 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 164 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 165 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 166 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 167 CANADA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 168 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 169 CANADA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 170 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 171 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 172 EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 173 EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 174 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 175 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 176 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 177 EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 178 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 179 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 180 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 181 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 182 EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 183 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 184 EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 185 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 186 GERMANY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 187 GERMANY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 188 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 189 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 190 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 191 GERMANY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 192 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 193 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 194 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 195 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 196 GERMANY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 197 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 198 GERMANY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 199 UK: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 200 UK: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 201 UK: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 202 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 203 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 204 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 205 UK: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 206 UK: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 207 UK: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 208 UK: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 209 UK: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 210 UK: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 211 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 212 UK: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 213 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 214 FRANCE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 215 FRANCE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 216 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 217 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 218 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 219 FRANCE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 220 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 221 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 222 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 223 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 224 FRANCE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 225 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 226 FRANCE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 227 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 228 ITALY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 229 ITALY: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 230 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 231 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 232 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 233 ITALY: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 234 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 235 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 236 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 237 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 238 ITALY: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 239 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 240 ITALY: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 241 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 242 SPAIN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 243 SPAIN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 244 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 245 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 246 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 247 SPAIN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 248 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 249 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 250 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 251 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 252 SPAIN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 253 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 254 SPAIN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 255 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 256 REST OF EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 257 REST OF EUROPE: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 258 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 259 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 260 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 261 REST OF EUROPE: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 262 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 263 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 264 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 265 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 266 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 267 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 268 REST OF EUROPE: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 269 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 270 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 271 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 272 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 273 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 274 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 275 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 276 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 277 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 278 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 279 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 280 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 281 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 282 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 283 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 284 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 285 CHINA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 286 CHINA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 287 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 288 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 289 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 290 CHINA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 291 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 292 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 293 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 294 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 295 CHINA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 296 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 297 CHINA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 298 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 299 JAPAN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 300 JAPAN: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 301 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 302 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 303 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 304 JAPAN: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 305 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 306 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 307 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 308 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 309 JAPAN: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 310 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 311 JAPAN: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 312 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 313 INDIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 314 INDIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 315 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 316 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 317 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 318 INDIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 319 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 320 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 321 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 322 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 323 INDIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 324 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 325 INDIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 326 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 327 AUSTRALIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 328 AUSTRALIA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 329 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 330 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 331 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 332 AUSTRALIA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 333 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 334 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 335 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 336 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 337 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 338 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 339 AUSTRALIA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 340 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 341 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 342 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 343 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 344 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 345 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 346 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 347 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 348 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 349 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 350 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 351 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 352 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 353 REST OF ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 354 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
TABLE 355 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 356 LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 357 LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 358 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 359 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 360 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 361 LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 362 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 363 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 364 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 365 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 366 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 367 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 368 LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 369 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 370 BRAZIL: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 371 BRAZIL: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 372 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 373 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 374 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 375 BRAZIL: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 376 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 377 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 378 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 379 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 380 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 381 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 382 BRAZIL: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 383 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 384 MEXICO: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 385 MEXICO: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 386 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 387 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 388 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 389 MEXICO: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 390 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 391 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 392 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 393 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 394 MEXICO: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 395 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 396 MEXICO: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 397 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 398 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 399 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 400 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 401 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 402 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 403 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 404 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 405 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 406 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 407 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 408 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 409 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 410 REST OF LATIN AMERICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 411 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY REGION, 2022-2030 (USD MILLION)
TABLE 412 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 413 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 414 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 415 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 416 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 417 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 418 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 419 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 420 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 421 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 422 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 423 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 424 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 425 MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 426 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 427 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 428 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 429 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 430 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 431 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 432 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 433 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 434 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 435 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 436 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 437 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 438 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 439 GCC COUNTRIES: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 440 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022-2030 (USD MILLION)
TABLE 441 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 442 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE HARDWARE MARKET FOR PATIENT MONITORING DEVICES, BY TYPE, 2022-2030 (USD MILLION)
TABLE 443 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022-2030 (USD MILLION)
TABLE 444 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022-2030 (USD MILLION)
TABLE 445 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE, 2022-2030 (USD MILLION)
TABLE 446 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022-2030 (USD MILLION)
TABLE 447 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022-2030 (USD MILLION)
TABLE 448 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022-2030 (USD MILLION)
TABLE 449 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE, BY TYPE, 2022-2030 (USD MILLION)
TABLE 450 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2022-2030 (USD MILLION)
TABLE 451 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022-2030 (USD MILLION)
TABLE 452 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 453 REST OF MIDDLE EAST & AFRICA: TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022-2030 (USD MILLION)
TABLE 454 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET, JANUARY 2021-JANUARY 2025
TABLE 455 TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION
TABLE 456 TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT
TABLE 457 TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT
TABLE 458 TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT
TABLE 459 TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT
TABLE 460 TELEHEALTH & TELEMEDICINE MARKET: END-USER FOOTPRINT
TABLE 461 TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 462 TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 463 TELEHEALTH & TELEMEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 464 TELEHEALTH & TELEMEDICINE MARKET: DEALS, JANUARY 2021-JANUARY 2025
TABLE 465 TELEHEALTH & TELEMEDICINE MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025
TABLE 466 TELEHEALTH & TELEMEDICINE MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 467 MEDTRONIC: COMPANY OVERVIEW
TABLE 468 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 469 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 470 MEDTRONIC: DEALS, JANUARY 2021-JANUARY 2025
TABLE 471 TELADOC HEALTH, INC.: COMPANY OVERVIEW
TABLE 472 TELADOC HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 473 TELADOC HEALTH, INC.: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
TABLE 474 TELADOC HEALTH, INC.: DEALS, JANUARY 2021-JANUARY 2025
TABLE 475 CISCO SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 476 CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 477 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 478 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 479 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 480 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021-JANUARY 2025
TABLE 481 ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW
TABLE 482 ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 483 ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2021-JANUARY 2025
TABLE 484 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 485 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 486 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 487 GE HEALTHCARE: DEALS, JANUARY 2021-JANUARY 2025
TABLE 488 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 489 EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 490 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021-JANUARY 2025
TABLE 491 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021-JANUARY 2025
TABLE 492 ORACLE: COMPANY OVERVIEW
TABLE 493 ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 494 ORACLE: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 495 ORACLE: DEALS, JANUARY 2021-JANUARY 2025
TABLE 496 DOXIMITY, INC.: COMPANY OVERVIEW
TABLE 497 DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 498 DOXIMITY, INC.: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025
TABLE 499 DOXIMITY, INC.: DEALS, JANUARY 2021-JANUARY 2025
TABLE 500 DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 501 AMERICAN WELL: COMPANY OVERVIEW
TABLE 502 AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 503 AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 504 AMERICAN WELL: DEALS, JANUARY 2021-JANUARY 2025
TABLE 505 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 506 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 507 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 508 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 509 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021-JANUARY 2025
TABLE 510 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): COMPANY OVERVIEW
TABLE 511 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 512 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): DEALS, JANUARY 2021-JANUARY 2025
TABLE 513 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.): OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 514 AMC HEALTH: COMPANY OVERVIEW
TABLE 515 AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 516 AMC HEALTH: DEALS, JANUARY 2021-JANUARY 2025
TABLE 517 TELESPECIALISTS: COMPANY OVERVIEW
TABLE 518 TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 519 TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 520 TELESPECIALISTS: DEALS, JANUARY 2021-JANUARY 2025
TABLE 521 TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 522 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY OVERVIEW
TABLE 523 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 524 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 525 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): DEALS, JANUARY 2021- JANUARY 2025
TABLE 526 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): EXPANSIONS, JANUARY 2021-JANUARY 2025
TABLE 527 CAREGILITY: COMPANY OVERVIEW
TABLE 528 CAREGILITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 529 CAREGILITY: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 530 CAREGILITY: DEALS, JANUARY 2021-JANUARY 2025
TABLE 531 CAREGILITY: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 532 CVS HEALTH: COMPANY OVERVIEW
TABLE 533 CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 534 CVS HEALTH: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 535 CVS HEALTH: DEALS, JANUARY 2021- JANUARY 2025
TABLE 536 EVERNORTH HEALTH, INC.: COMPANY OVERVIEW
TABLE 537 EVERNORTH HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 538 EVERNORTH HEALTH, INC.: DEALS, JANUARY 2021-JANUARY 2025
TABLE 539 ELATION: COMPANY OVERVIEW
TABLE 540 ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 541 ELATION: DEALS, JANUARY 2021-JANUARY 2025
TABLE 542 IRON BOW TECHNOLOGIES: COMPANY OVERVIEW
TABLE 543 IRON BOW TECHNOLOGIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 544 TIMEDOC, INC.: COMPANY OVERVIEW
TABLE 545 CEREBRAL INC.: COMPANY OVERVIEW
TABLE 546 KINDBODY: COMPANY OVERVIEW
TABLE 547 TRANSACARENT: COMPANY OVERVIEW
TABLE 548 CARESIMPLE INC.: COMPANY OVERVIEW

List of Figures

FIGURE 1 TELEHEALTH & TELEMEDICINE MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
FIGURE 2 TELEHEALTH & TELEMEDICINE MARKET: YEARS CONSIDERED
FIGURE 3 TELEHEALTH & TELEMEDICINE MARKET: RESEARCH DESIGN
FIGURE 4 TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5 TELEHEALTH & TELEMEDICINE MARKET: KEY SOURCES OF PRIMARY DATA
FIGURE 6 TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 7 TELEHEALTH & TELEMEDICINE MARKET: INSIGHTS FROM PRIMARIES
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 10 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 11 BOTTOM-UP APPROACH: END-USER SPENDING ON TELEHEALTH & TELEMEDICINE
FIGURE 12 TELEHEALTH & TELEMEDICINE MARKET: TOP-DOWN APPROACH
FIGURE 13 TELEHEALTH & TELEMEDICINE MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2030)
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 15 TELEHEALTH & TELEMEDICINE MARKET: DATA TRIANGULATION
FIGURE 16 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION)
FIGURE 17 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)
FIGURE 18 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)
FIGURE 19 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP, 2024 VS. 2030 (USD MILLION)
FIGURE 20 TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
FIGURE 21 TELEHEALTH & TELEMEDICINE MARKET: REGIONAL SNAPSHOT
FIGURE 22 NEED TO IMPROVE ACCESSIBILITY AND REDUCE HEALTHCARE EXPENSES TO DRIVE MARKET
FIGURE 23 US AND HEALTHCARE PROVIDERS COMMANDED LARGEST MARKET SHARE IN 2023
FIGURE 24 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
FIGURE 25 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 26 TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 27 INCREASE IN POPULATION, 2022 VS. 2030 VS. 2050 (MILLION)
FIGURE 28 US: MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS, BY STATE (SEPTEMBER 2024)
FIGURE 29 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009-2024
FIGURE 30 US: MEDIAN HEALTHCARE DATA BREACH SIZE, 2009-2024
FIGURE 31 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009-2023
FIGURE 32 TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
FIGURE 33 TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS
FIGURE 34 TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS
FIGURE 35 TELEHEALTH & TELEMEDICINE MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 36 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
FIGURE 37 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS
FIGURE 38 GLOBAL PATENT PUBLICATION TRENDS IN TELEHEALTH & TELEMEDICINE, 2015-2024
FIGURE 39 JURISDICTION AND TOP APPLICANT ANALYSIS IN TELEHEALTH & TELEMEDICINE (2024)
FIGURE 40 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR TELEHEALTH & TELEMEDICINE (JANUARY 2015-DECEMBER 2024)
FIGURE 41 FUNDING AND NUMBER OF DEALS IN TELEHEALTH & TELEMEDICINE MARKET
FIGURE 42 POTENTIAL OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET
FIGURE 43 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT
FIGURE 44 ASIA PACIFIC: TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT
FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET, 2019-2023 (USD MILLION)
FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET (2023)
FIGURE 47 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 48 TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT
FIGURE 49 TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 50 EV/EBITDA OF KEY VENDORS, 2024
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
FIGURE 52 TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
FIGURE 53 MEDTRONIC: COMPANY SNAPSHOT
FIGURE 54 TELADOC HEALTH, INC.: COMPANY SNAPSHOT
FIGURE 55 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT
FIGURE 56 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
FIGURE 57 ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT
FIGURE 58 GE HEALTHCARE: COMPANY SNAPSHOT
FIGURE 59 ORACLE: COMPANY SNAPSHOT
FIGURE 60 DOXIMITY, INC.: COMPANY SNAPSHOT
FIGURE 61 AMERICAN WELL: COMPANY SNAPSHOT
FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
FIGURE 63 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY SNAPSHOT
FIGURE 64 CVS HEALTH: COMPANY SNAPSHOT
FIGURE 65 EVERNORTH HEALTH, INC.: COMPANY SNAPSHOT

Product Code: HIT 3542

The telehealth and telemdicine market is projected to reach USD 180.86 billion by 2030 from USD 94.14 billion in 2024, at a CAGR of 11.5% from 2024 to 2030. The telehealth and telemedicine market is rapidly expanding due to a variety of factors such as advancement in telecommunication technologies, government support and regulatory policies, and expansion of remote patient moniytoring systems. An aging population necessitates continuous monitoring of chronic conditions, creating a growing demand for cost-effective healthcare solutions. Furthermore, the rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, emphasizes the value of remote care. Telemedicine saves a lot of time and money, hence becoming attractive for both patients and providers. The advancements in the field of telecommunications technology along with the increasing adoption of remote patient monitored technologies have enhanced the virtual care success rate and market adoption, while government support through favorable regulation and reimbursable frameworks has helped in market expansion.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2023
Forecast Period	2024-2030
Units Considered	Value (USD)
Segments	Component, Function, Application, Age Group, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, and Middle East Africa

"Patients segment had the fastest growth rate in the telehealth & telemedicine market during the forecast period, by end user."

By end user, the patients segment is the fastest growing segment in the telehealth and telemedicine market during the forecast period. This is mainly due to the growing adoption of remote healthcare services, which enable patients to receive medical consultations and treatment from the comfort of their own homes. The factors that have contributed to the increase include growing chronic conditions, the need for convenient and timely medical care, and the increasing awareness of the benefits of telemedicine. The COVID-19 pandemic had also been an accelerator of telehealth, with patients seeking safer alternatives to in-person visits. Other factors that are driving this market segment include enhanced patient comfort, reduced healthcare costs, and improved access to specialists, especially in rural or underserved areas.

"By component, software segment to accounted for the largest market share in the telehealth and telemedicine market."

Based on component, the software segment accounted for the largest market share in the telehealth and telemedicine market. This is due to the increase in the use of telehealth platforms for virtual consultation, remote patient monitoring, and electronic health record management. With use of digital resources by healthcare providers becoming widespread in delivering care in an efficient manner, software for video conferencing, appointment scheduling, secure messaging and data analytics, are fast becoming critical. The integration of artificial intelligence (AI) and machine learning in telemedicine application software also is accelerateing market expansion, providing enhanced diagnostic capabilities, tailored clinical management, and better outcomes for the patient. Moreover, the rising focus on seamless interoperability between healthcare systems and regulatory compliance for data security and privacy further accelerates the demand for advanced telehealth software.

"Asia Pacific is estimated to register the fastest CAGR over the forecast period."

The telehealth & telemdicine market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific telehealth & telemdicine market is projected to register fastest CAGR during the forecast period. The Asia Pacific is benefiting from the fast-developing healthcare infrastructure, advances in digital technologies. It is due to multiple factors such as the rising use of digital healthcare products, healthcare needs resulting from large and ageing populations, as well as an increasing incidence of chronic diseases. Moreover, internet penetration and mobile penetration have broadened in areas such as India and China, which in turn have accelerated the growth in telehealth services. Government activities promoting telemedicine and improvements in digital health infrastructure also play a role in contributing to the growth of telehealth and telemedicine market.

Breakdown of supply-side primary interviews by company type, designation, and region:

By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
By Designation: Managers (40%), Directors (35%), and Others (25%)
By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%) and Middle East & Africa (2%)

List of Companies Profiled in the Report:

1. Koninklijke Philips N.V. (Netherlands)

2. Medtronic (Ireland)

3. GE Healthcare (US)

4. Epic Systems Corporation (US)

5. Oracle (US)

6. Doximity, Inc. (US)

7. Teladoc Health, Inc. (US)

8. American Well (US)

9. Siemens Healthineers AG (Germany)

10. Cisco Systems Inc. (US)

11. Included Health, Inc. (Doctor on Demand, Inc.) (US)

12. AMC Health (US)

13. TeleSpecialists (US)

14. Walgreen Co. (US)

15. Caregility (US)

16. CVS Health (US)

17. EverNorth Health, Inc. (US)

18. Elation (US)

19. Iron Bow Healthcare Solutions (US)

20. ZoomCommunications, Inc. (US)

21. Timedoc Health (US)

22. Cerebral Inc. (US)

23. Kindbody (US)

24. Transcarent (US)

25. Caresimple, Inc. (US)

Research Coverage:

This research report categorizes the telehealth & telemedicine market by component (Hardware (Telehealth Kits, Carts, And Stations, Patient Monitoring Devices (Cardiac Monitoring Devices, Neurological Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitoring Devices, Fetal & Neonatal Monitoring Devices, Weight Monitoring Devices, Multiparameter Monitoring Devices, Pulse Oximeter Devices, Other Monitoring Devices)), Software (By Modality: EHR Centric, Non-EHR Centric, By Integration Type: Integrated Software, Standalone Software, By Type: Remote Patient Monitoring, Virtual Care Platforms (Real-Time Interaction, Store & Forward), Video Conferencing platforms, Virtual sitting & Nursing, By Deployment: On-premise model, Cloud-based model), and Services). By Function (Clinical Care Management (Including Teleconsultation & Follow-Up), Preventive Care Management, Diagnostics & Treatment, Remote Patient Monitoring/Patient Monitoring, Rehabilitation & Recovery, Administrative, Analytics & Reporting, Patient Engagement, Other Functions (Clinical Trials, Education, Training, and Others), By Application (Primary Care, Speciality Care (Teleradiology, Telecardiology, Teleneurology, Diabetes, Respiratory Disorders (COPD, Asthma, And Others), Hypertension, Teledermatology, Telestroke, Telepsychiatry (Mental Health), Others (Dental, Oncology, Obstetrics, Gynaecology, Ophthalmology, Metabolic Disorders, Immunology, Gastroenterology, Nephrology & Urology, Rare Disease, Infectious Diseases, And Others), TeleICU, Virtual Sitting & Nursing, Other Applications (Clinical Trials, Emergency & Urgent Care, General Wellness & Lifestyle Improvement, Occupational Health, and Others), By Age Group (Pediatrics, Adults, Geriatrics), By End User (Healthcare Providers (Hospitals, Ambulatory Surgical Centers, Ambulatory Care Centers, and Other Outpatient Settings, Long Term Care & Assisted Living Facilities, Home Healthcare, Other Healthcare Providers (Diagnostics & Imagining Centers, Rehabilitation Centers, Behavioural Health Centers, and Others), Healthcare Payers (Public Payers, Private Payers), Patients, Pharmaceutical & Biotechnology Companies, Medtech Companies, Other End Users (Medtech Companies, Academic Institutes, Research Centers, Government Organizations, and Others)) and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the telehealth & telemedicine market. A thorough analysis of the key industry players has been done to provide insights into their business overview, offerings, and key strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the telehealth & telemedicine market. Competitive analysis of upcoming startups in the telehealth & telemedicine market ecosystem is covered in this report.

Reasons to Buy the Report

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall telehealth & telemedicine market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers: (Growing geriatric population and increasing need to expand healthcare access, Rising prevalence of chronic conditions, Demonstrated Time and Cost Savings, Advancements in telecommunication technologies, Shortage of skilled healthcare professionals, Government support & Regulatory policies, Expansion of Remote Patient Monitoring (RPM) systems), restraints (High investment costs and lack of IT expertise, Regulatory variations across regions, Behavioral reluctance to adopt new technologies, Rise in fraud and abuse within healthcare systems, Patient privacy and confidentiality, adhering to medical ethics), opportunities (Growing use of wearables, apps, and sensors for virtual care, Emergence of AI/ML, Increasing shift towards outpatient care models, High utility of telemedicine against infectious diseases and epidemics, Expansion of hospital-at-home initiatives, Demand for EMR-based telehealth, Rapid growth of mental health care), and challenges (Data security concerns, Limited data accessibility, Inability to maintain hygiene and cleanliness standards) influencing the growth of the telehealth & telemedicine market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the telehealth & telemedicine market.
Market Development: Comprehensive information about lucrative markets - the report analyses the telehealth & telemedicine market across varied regions.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the telehealth & telemedicine market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), etc. among others in telehealth & telemedicine market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
- 1.2.1 TELEHEALTH
- 1.2.2 TELEMEDICINE
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & GEOGRAPHICAL SPREAD
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key sources of secondary data
  - 2.1.1.2 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Key sources of primary data
  - 2.1.2.2 Key objectives of primary research
  - 2.1.2.3 Key data from primary sources
  - 2.1.2.4 Insights from primary experts
2.2 RESEARCH APPROACH
2.3 MARKET SIZE ESTIMATION
- 2.3.1 REVENUE SHARE ANALYSIS (SUPPLY-SIDE ANALYSIS)
- 2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION)
- 2.3.3 TOP-DOWN APPROACH
- 2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.4 DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
- 2.7.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 TELEHEALTH & TELEMEDICINE MARKET OVERVIEW
4.2 NORTH AMERICA: TELEHEALTH & TELEMEDICINE MARKET, BY END USER AND REGION
4.3 TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT
4.4 TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Growing geriatric population and increasing need for advanced healthcare infrastructure
  - 5.2.1.2 Rising prevalence of chronic diseases
  - 5.2.1.3 Reduced time and lower out-of-pocket costs
  - 5.2.1.4 Advancements in telecommunication technologies
  - 5.2.1.5 Shortage of skilled healthcare professionals
  - 5.2.1.6 Increased government support and favorable regulatory policies
  - 5.2.1.7 Expansion of remote patient monitoring systems
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High investment costs for B2B models and lack of IT expertise
  - 5.2.2.2 State-to-state and inter-country regulatory variations
  - 5.2.2.3 Behavioral reluctance to adopt new technologies
  - 5.2.2.4 Rise in fraud and abuse in healthcare systems
  - 5.2.2.5 Adherence to patient privacy, confidentiality, medical ethics
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Growing use of wearables, applications, and sensors for virtual care
  - 5.2.3.2 Emergence of AI and ML
  - 5.2.3.3 Increasing shift toward outpatient care models
  - 5.2.3.4 High utility of telemedicine against infectious communicable diseases and epidemics
  - 5.2.3.5 Expansion of hospital-at-home (HaH) initiatives
  - 5.2.3.6 Demand for electronic medical record-based telehealth services
  - 5.2.3.7 Rising incidence of mental illnesses and growing focus on emotional well-being
- 5.2.4 CHALLENGES
  - 5.2.4.1 Data security and confidentiality concerns
  - 5.2.4.2 Limited data accessibility
  - 5.2.4.3 Inability to maintain patient hygiene and cleanliness standards
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.4 INDUSTRY TRENDS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
- 5.7.1 KEY TECHNOLOGIES
  - 5.7.1.1 Video conferencing and real-time communication platforms
  - 5.7.1.2 AI and ML
  - 5.7.1.3 Virtual assistants and chatbots
  - 5.7.1.4 Voice recognition and natural language processing
  - 5.7.1.5 EHR integration
  - 5.7.1.6 Remote patient monitoring systems
- 5.7.2 COMPLEMENTARY TECHNOLOGIES
  - 5.7.2.1 Edge computing
  - 5.7.2.2 Cloud computing
  - 5.7.2.3 Mobile health (mHealth) applications
  - 5.7.2.4 Wearable devices, sensors, and IoT
- 5.7.3 ADJACENT TECHNOLOGIES
  - 5.7.3.1 Digital therapeutics
  - 5.7.3.2 Blockchain technology
  - 5.7.3.3 Augmented reality and virtual reality
5.8 TARIFF AND REGULATORY ANALYSIS
- 5.8.1 TARIFF DATA ANALYSIS
  - 5.8.1.1 Tariff data for HS code 9018
  - 5.8.1.2 Tariff data for HS code 9021
  - 5.8.1.3 Tariff data for HS code 9022
- 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.8.3 REGULATORY STANDARDS
- 5.8.4 REGULATORY FRAMEWORK
5.9 TRADE ANALYSIS
- 5.9.1 TRADE DATA FOR HSN CODE 90189099
  - 5.9.1.1 Top 10 importers for HSN code 90189099
  - 5.9.1.2 Top 10 exporters for HSN code 90189099
- 5.9.2 TRADE DATA FOR HSN CODE 9021
  - 5.9.2.1 Top 10 importers for HSN code 9021
  - 5.9.2.2 Top 10 exporters for HSN code 9021
- 5.9.3 TRADE DATA FOR HSN CODE 9022
  - 5.9.3.1 Top 10 importers for HSN code 9022
  - 5.9.3.2 Top 10 exporters for HSN code 9022
5.10 PRICING ANALYSIS
- 5.10.1 INDICATIVE PRICING FOR TELEHEALTH & TELEMEDICINE SOLUTIONS, BY COMPONENT, 2023
- 5.10.2 INDICATIVE PRICING OF TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2023
- 5.10.3 PRICING MODELS
5.11 PORTER'S FIVE FORCES ANALYSIS
- 5.11.1 THREAT OF NEW ENTRANTS
- 5.11.2 THREAT OF SUBSTITUTES
- 5.11.3 BARGAINING POWER OF BUYERS
- 5.11.4 BARGAINING POWER OF SUPPLIERS
- 5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.12.2 KEY BUYING CRITERIA
5.13 PATENT ANALYSIS
- 5.13.1 PATENT PUBLICATION TRENDS FOR TELEHEALTH & TELEMEDICINE
- 5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.14 UNMET NEEDS & END-USER EXPECTATIONS
- 5.14.1 UNMET NEEDS
- 5.14.2 END-USER EXPECTATIONS
5.15 KEY CONFERENCES & EVENTS, 2025-2026
5.16 CASE STUDY ANALYSIS
- 5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH TEBRA'S INTEGRATED SOLUTIONS
- 5.16.2 USE OF TELEHEALTH TO REDUCE PREVENTABLE EMERGENCY ROOM TRANSFERS FROM SKILLED NURSING FACILITIES
- 5.16.3 CONE HEALTH TO REVOLUTIONIZE TELEHEALTH FOR TRANSITION TO CAREGILITY'S UNIVERSAL HEALTH ENGAGEMENT SOLUTIONS
5.17 INVESTMENT & FUNDING SCENARIO
5.18 BUSINESS MODEL ANALYSIS
- 5.18.1 DIRECT-TO-PATIENT (D2P) MODEL
- 5.18.2 BUSINESS-TO-BUSINESS (B2B) MODEL
- 5.18.3 EMPLOYER-SPONSORED MODEL
- 5.18.4 SUBSCRIPTION-BASED MODEL
- 5.18.5 HYBRID TELEMEDICINE MODEL
- 5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODEL
- 5.18.7 VALUE-BASED CARE MODEL
5.19 IMPACT OF AI/GEN AI IN TELEHEALTH & TELEMEDICINE MARKET
- 5.19.1 KEY USE CASES
- 5.19.2 MAJOR CASE STUDIES
  - 5.19.2.1 AI to redefine treatment effectiveness and safety
  - 5.19.2.2 AI-driven chatbots and telehealth to enhance mental health and chronic disease management
- 5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  - 5.19.3.1 Healthcare IT and EHR systems
  - 5.19.3.2 Pharmaceuticals & drug discovery
  - 5.19.3.3 Mental health tech
  - 5.19.3.4 Healthcare analytics and insights
- 5.19.4 USER READINESS & IMPACT ASSESSMENT
  - 5.19.4.1 User readiness
    - 5.19.4.1.1 User A: Hospitals
    - 5.19.4.1.2 User B: Ambulatory surgery centers
  - 5.19.4.2 Impact assessment
    - 5.19.4.2.1 User A: Hospitals
    - 5.19.4.2.2 User B: Ambulatory surgery centers
5.20 REIMBURSEMENT SCENARIO ANALYSIS

6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT

6.1 INTRODUCTION
6.2 HARDWARE
- 6.2.1 TELEHEALTH KITS, CARTS, AND STATIONS
  - 6.2.1.1 Increased focus on streamlined workflows and quality of remote healthcare services to drive adoption
- 6.2.2 PATIENT MONITORING DEVICES
  - 6.2.2.1 Cardiac monitoring devices
    - 6.2.2.1.1 Cardiac monitoring telehealth devices to minimize need for frequent hospital visits and improve patient outcomes
  - 6.2.2.2 Neurological monitoring devices
    - 6.2.2.2.1 Focus on better neuro care with advanced telemedicine solutions to augment segment growth
  - 6.2.2.3 Respiratory monitoring devices
    - 6.2.2.3.1 Rising prevalence of respiratory diseases and demand for home-based healthcare to drive segment
  - 6.2.2.4 Blood glucose monitoring devices
    - 6.2.2.4.1 Increasing number of diabetic patients in low- and middle-income countries to augment need for remote monitoring
  - 6.2.2.5 Fetal & neonatal monitoring devices
    - 6.2.2.5.1 Focus on continuous and personalized care without frequent in-person visits to drive segment
  - 6.2.2.6 Weight monitoring devices
    - 6.2.2.6.1 Rising prevalence of obesity and increasing awareness about weight management to drive market
  - 6.2.2.7 Multiparameter monitoring devices
    - 6.2.2.7.1 Rise of home healthcare and increased demand for remote patient monitoring to propel segment growth
  - 6.2.2.8 Pulse oximeter devices
    - 6.2.2.8.1 Remote pulse oximeter devices to manage chronic respiratory conditions and help faster patient recovery
  - 6.2.2.9 Other patient monitoring devices
6.3 SOFTWARE
- 6.3.1 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY
  - 6.3.1.1 EHR-centric software
    - 6.3.1.1.1 EHR-centric software to improve patient information accessibility and secure sharing across platforms
  - 6.3.1.2 Non-EHR-centric software
    - 6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate telehealth services without constraints
- 6.3.2 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE
  - 6.3.2.1 Integrated software
    - 6.3.2.1.1 Integrated software to streamline clinical workflow and promote better access to patient health data
  - 6.3.2.2 Standalone software
    - 6.3.2.2.1 Increased focus on flexibility and ease of usage to fuel adoption
- 6.3.3 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY TYPE
  - 6.3.3.1 Remote patient monitoring platforms
    - 6.3.3.1.1 Increased popularity of at-home chronic disease management among geriatric patients to aid market growth
  - 6.3.3.2 Virtual care platforms
    - 6.3.3.2.1 Real-time interaction platforms
      - 6.3.3.2.1.1 Synchronous nature and better healthcare access to drive segment
    - 6.3.3.2.2 Store & forward platforms
      - 6.3.3.2.2.1 Easy monitoring of vital signs for long-term chronic care without physical presence to fuel segment growth
  - 6.3.3.3 Video conferencing platforms
    - 6.3.3.3.1 Need for collaborative and coordinated care for chronic patients to augment segment growth
  - 6.3.3.4 Virtual sitting & nursing platforms
    - 6.3.3.4.1 Reduced workload of on-site staff and prevention of costly hospital readmissions to boost segment growth
- 6.3.4 TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT
  - 6.3.4.1 On-premise deployment models
    - 6.3.4.1.1 Enhanced control and safety of inventory data with better reuse of existing infrastructure to drive market
  - 6.3.4.2 Cloud-based deployment models
    - 6.3.4.2.1 Need to integrate information from disparate locations in real time for database registry to drive segment
6.4 SERVICES
- 6.4.1 COST-EFFECTIVENESS AND REDUCED STRAIN ON HEALTHCARE PROVIDERS TO DRIVE MARKET

7 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION

7.1 INTRODUCTION
7.2 CLINICAL CARE MANAGEMENT
- 7.2.1 FOCUS ON REAL-TIME CONSULTATIONS, PROACTIVE MONITORING, AND FOLLOW-UP STRATEGIES TO DRIVE MARKET
7.3 PREVENTIVE CARE MANAGEMENT
- 7.3.1 PREVENTIVE CARE AMONG RURAL PATIENTS TO REDUCE DELAYED DIAGNOSIS AND IMPROVE PATIENT ENGAGEMENT
7.4 DIAGNOSTICS & TREATMENT
- 7.4.1 DIAGNOSIS & TREATMENT TO SUPPORT PROACTIVE CARE MANAGEMENT AND DEVELOP PERSONAL HEALTHCARE PLANS
7.5 REMOTE PATIENT MONITORING/PATIENT MONITORING
- 7.5.1 REMOTE PATIENT MONITORING TO REVOLUTIONIZE PATIENT CARE BY IMPROVING ACCESSIBILITY, EFFICIENCY, AND HEALTH OUTCOMES
7.6 REHABILITATION & RECOVERY
- 7.6.1 ADOPTION OF TELEREHABILITATION TO OVERCOME REGIONAL BARRIERS AND SUPPORT PATIENTS WITH MOBILITY CHALLENGES
7.7 ADMINISTRATIVE
- 7.7.1 EFFICIENT ADMINISTRATIVE TASKS TO ENHANCE WORKFLOW AND IMPROVE OPERATIONAL EFFICIENCY
7.8 ANALYTICS & REPORTING
- 7.8.1 ADVANCED DATA ANALYTICS & REPORTING TO SUPPORT PROACTIVE DECISION-MAKING AND FOSTER BETTER CARE COORDINATION
7.9 PATIENT ENGAGEMENT
- 7.9.1 PROACTIVE PATIENT ENGAGEMENT TO PROMOTE ADHERENCE TO TREATMENT PLANS AND ENABLE TIMELY INTERVENTIONS
7.10 OTHER FUNCTIONS

8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 PRIMARY CARE
- 8.2.1 TECHNOLOGICAL ADVANCEMENTS AND CONVENIENT ACCESS TO HEALTHCARE FACILITIES TO AID MARKET GROWTH
8.3 SPECIALTY CARE
- 8.3.1 TELERADIOLOGY
  - 8.3.1.1 Rise of cloud-based imaging solutions and AI-driven radiology tools to boost segment growth
- 8.3.2 TELECARDIOLOGY
  - 8.3.2.1 Integration of AI, cloud-based ECG monitoring, and wearable health devices to fuel segment growth
- 8.3.3 TELENEUROLOGY
  - 8.3.3.1 High prevalence of neurological disorders and incorporation of AI into diagnostic tools to spur segment growth
- 8.3.4 DIABETES
  - 8.3.4.1 Rise in consumer demand for more accessible and cost-effective healthcare services to augment market growth
- 8.3.5 RESPIRATORY DISORDERS
  - 8.3.5.1 Increasing global prevalence of chronic respiratory conditions among older adults to fuel market growth
- 8.3.6 HYPERTENSION
  - 8.3.6.1 Need for continuous monitoring and rise of remote care technologies to propel market growth
- 8.3.7 TELEDERMATOLOGY
  - 8.3.7.1 High prevalence of skin cancer and dermatology-related diseases to augment segment growth
- 8.3.8 TELESTROKE
  - 8.3.8.1 Rising incidence of stroke and increasing geriatric population to drive market
- 8.3.9 TELEPSYCHIATRY
  - 8.3.9.1 Shortage of mental health practitioners and poor access to psychiatric care in rural areas to fuel market growth
- 8.3.10 OTHER SPECIALTY CARE APPLICATIONS
8.4 TELEICU
- 8.4.1 INCREASED EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF SPECIALISTS TO SUPPORT MARKET GROWTH
8.5 VIRTUAL SITTING & NURSING
- 8.5.1 INCREASING DEMAND FOR HOME-BASED HEALTHCARE SERVICES TO FUEL MARKET GROWTH
8.6 OTHER APPLICATIONS

9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP

9.1 INTRODUCTION
9.2 PEDIATRICS
- 9.2.1 INCREASING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE FOR CHILDREN IN RURAL AREAS TO DRIVE MARKET
9.3 ADULTS
- 9.3.1 HIGH DEMAND FOR REMOTE ROUTINE CHECK-UPS AND CHRONIC DISEASE MANAGEMENT TO PROPEL MARKET GROWTH
9.4 GERIATRICS
- 9.4.1 RISING GERIATRIC POPULATION TO AUGMENT NEED FOR REMOTE MEDICAL CONSULTATIONS

10 TELEHEALTH & TELEMEDICINE MARKET, BY END USER

10.1 INTRODUCTION
10.2 HEALTHCARE PROVIDERS
- 10.2.1 HOSPITALS
  - 10.2.1.1 Increasing demand for advanced and high-quality to drive market
- 10.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS
  - 10.2.2.1 High preference, minimized patient downtime, and reduced hospital stay to augment segment growth
- 10.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES
  - 10.2.3.1 Need for prolonged treatment for chronic diseases and preference for participatory and preventive care to drive segment
- 10.2.4 HOME HEALTHCARE
  - 10.2.4.1 Rising prevalence of chronic diseases and need for cost-effective solutions to aid market growth
- 10.2.5 OTHER HEALTHCARE PROVIDERS
10.3 HEALTHCARE PAYERS
- 10.3.1 PUBLIC HEALTHCARE PAYERS
  - 10.3.1.1 Increasing healthcare R&D investments and favorable policies to drive segment
- 10.3.2 PRIVATE HEALTHCARE PAYERS
  - 10.3.2.1 Implementation of telehealth services for mental health issues and substance usage to drive segment
10.4 PATIENTS
- 10.4.1 RISING GERIATRIC POPULATION TO INCREASE FOCUS ON TELEHEALTH SERVICES FOR LONG-TERM CARE NEEDS
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 10.5.1 RISE OF VIRTUAL CONSULTATIONS AND TELEMEDICINE PLATFORMS TO INCREASE CLINICAL TRIALS WITHOUT REGIONAL BARRIERS
10.6 MEDTECH COMPANIES
- 10.6.1 INCREASED DEMAND FOR INNOVATIVE HEALTHCARE DEVICES FOR REMOTE DIAGNOSIS AND TREATMENT TO AID MARKET GROWTH
10.7 OTHER END USERS

11 TELEHEALTH & TELEMEDICINE MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
- 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 11.2.2 US
  - 11.2.2.1 US to dominate North American telehealth & telemedicine market during study period
- 11.2.3 CANADA
  - 11.2.3.1 Push for digital health integration to drive higher adoption of telehealth services
11.3 EUROPE
- 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 11.3.2 GERMANY
  - 11.3.2.1 Favorable government legislation for digitalized healthcare to spur market growth
- 11.3.3 UK
  - 11.3.3.1 Increased government focus on digital health solutions to aid market growth
- 11.3.4 FRANCE
  - 11.3.4.1 Strategic investments and government policy reforms to fuel uptake of digital medical devices for treatment
- 11.3.5 ITALY
  - 11.3.5.1 Increased government healthcare investments to foster greater efficiency and accessibility in digital health solutions
- 11.3.6 SPAIN
  - 11.3.6.1 Developed eHealth sector and increased adoption of wearable health tracking devices to augment market growth
- 11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
- 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 11.4.2 CHINA
  - 11.4.2.1 Investments in digital healthcare solutions to drive market
- 11.4.3 JAPAN
  - 11.4.3.1 Favorable legal revisions and advancements in video and audio communication to aid market growth
- 11.4.4 INDIA
  - 11.4.4.1 Ongoing digital transformation initiatives through favorable government schemes to support market adoption
- 11.4.5 AUSTRALIA
  - 11.4.5.1 Significant government investments in rural, remote, and specialist aged care services to fuel uptake
- 11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
- 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 11.5.2 BRAZIL
  - 11.5.2.1 Increased availability of smartphones and improved internet connectivity to propel market growth
- 11.5.3 MEXICO
  - 11.5.3.1 Regulatory improvements in telemedicine consultations to boost market growth
- 11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
- 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 11.6.2 GCC COUNTRIES
  - 11.6.2.1 Shortage of healthcare workforce to drive adoption of telehealth services
- 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TELEHEALTH & TELEMEDICINE MARKET
12.3 REVENUE ANALYSIS, 2019-2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 12.5.1 STARS
- 12.5.2 EMERGING LEADERS
- 12.5.3 PERVASIVE PLAYERS
- 12.5.4 PARTICIPANTS
- 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 12.5.5.1 Company footprint
  - 12.5.5.2 Region footprint
  - 12.5.5.3 Function footprint
  - 12.5.5.4 Application footprint
  - 12.5.5.5 Component footprint
  - 12.5.5.6 End-user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.6.1 PROGRESSIVE COMPANIES
- 12.6.2 RESPONSIVE COMPANIES
- 12.6.3 DYNAMIC COMPANIES
- 12.6.4 STARTING BLOCKS
- 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  - 12.6.5.1 Detailed list of key startups/SMEs
  - 12.6.5.2 Competitive benchmarking of key startups/SMEs
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.8 BRAND/SOFTWARE COMPARATIVE ANALYSIS
12.9 COMPETITIVE SCENARIO
- 12.9.1 PRODUCT LAUNCHES & APPROVALS
- 12.9.2 DEALS
- 12.9.3 EXPANSIONS
- 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES

13.1 KEY PLAYERS
- 13.1.1 MEDTRONIC
  - 13.1.1.1 Business overview
  - 13.1.1.2 Products/Services/Solutions offered
  - 13.1.1.3 Recent developments
    - 13.1.1.3.1 Product launches & approvals
    - 13.1.1.3.2 Deals
  - 13.1.1.4 MnM view
    - 13.1.1.4.1 Right to win
    - 13.1.1.4.2 Strategic choices
    - 13.1.1.4.3 Weaknesses & competitive threats
- 13.1.2 TELADOC HEALTH, INC.
  - 13.1.2.1 Business overview
  - 13.1.2.2 Products/Services/Solutions offered
  - 13.1.2.3 Recent developments
    - 13.1.2.3.1 Product launches & enhancements
    - 13.1.2.3.2 Deals
  - 13.1.2.4 MnM view
    - 13.1.2.4.1 Right to win
    - 13.1.2.4.2 Strategic choices
    - 13.1.2.4.3 Weaknesses & competitive threats
- 13.1.3 CISCO SYSTEMS, INC.
  - 13.1.3.1 Business overview
  - 13.1.3.2 Products/Services/Solutions offered
  - 13.1.3.3 MnM view
    - 13.1.3.3.1 Right to win
    - 13.1.3.3.2 Strategic choices
    - 13.1.3.3.3 Weaknesses & competitive threats
- 13.1.4 KONINKLIJKE PHILIPS N.V.
  - 13.1.4.1 Business overview
  - 13.1.4.2 Products/Services/Solutions offered
  - 13.1.4.3 Recent developments
    - 13.1.4.3.1 Product launches & approvals
    - 13.1.4.3.2 Deals
  - 13.1.4.4 MnM view
    - 13.1.4.4.1 Right to win
    - 13.1.4.4.2 Strategic choices
    - 13.1.4.4.3 Weaknesses & competitive threats
- 13.1.5 ZOOM COMMUNICATIONS, INC.
  - 13.1.5.1 Business overview
  - 13.1.5.2 Products/Services/Solutions offered
  - 13.1.5.3 Recent developments
    - 13.1.5.3.1 Deals
  - 13.1.5.4 MnM view
    - 13.1.5.4.1 Right to win
    - 13.1.5.4.2 Strategic choices
    - 13.1.5.4.3 Weaknesses & competitive threats
- 13.1.6 GE HEALTHCARE
  - 13.1.6.1 Business overview
  - 13.1.6.2 Products/Services/Solutions offered
  - 13.1.6.3 Recent developments
    - 13.1.6.3.1 Product launches & approvals
    - 13.1.6.3.2 Deals
- 13.1.7 EPIC SYSTEMS CORPORATION
  - 13.1.7.1 Business overview
  - 13.1.7.2 Products/Services/Solutions offered
  - 13.1.7.3 Recent developments
    - 13.1.7.3.1 Product launches & enhancements
    - 13.1.7.3.2 Deals
- 13.1.8 ORACLE
  - 13.1.8.1 Business overview
  - 13.1.8.2 Products/Services/Solutions offered
  - 13.1.8.3 Recent developments
    - 13.1.8.3.1 Product launches
    - 13.1.8.3.2 Deals
- 13.1.9 DOXIMITY, INC.
  - 13.1.9.1 Business overview
  - 13.1.9.2 Products/Services/Solutions offered
  - 13.1.9.3 Recent developments
    - 13.1.9.3.1 Product enhancements
    - 13.1.9.3.2 Deals
    - 13.1.9.3.3 Other developments
- 13.1.10 AMERICAN WELL
  - 13.1.10.1 Business overview
  - 13.1.10.2 Products/Services/Solutions offered
  - 13.1.10.3 Recent developments
    - 13.1.10.3.1 Product launches
    - 13.1.10.3.2 Deals
    - 13.1.10.3.3 Other developments
- 13.1.11 SIEMENS HEALTHINEERS AG
  - 13.1.11.1 Business overview
  - 13.1.11.2 Products/Services/Solutions offered
  - 13.1.11.3 Recent developments
    - 13.1.11.3.1 Product launches & approvals
    - 13.1.11.3.2 Deals
- 13.1.12 INCLUDED HEALTH, INC. (DOCTOR ON DEMAND, INC.)
  - 13.1.12.1 Business overview
  - 13.1.12.2 Products/Services/Solutions offered
  - 13.1.12.3 Recent developments
    - 13.1.12.3.1 Deals
    - 13.1.12.3.2 Other developments
- 13.1.13 AMC HEALTH
  - 13.1.13.1 Business overview
  - 13.1.13.2 Products/Services/Solutions offered
  - 13.1.13.3 Recent developments
    - 13.1.13.3.1 Deals
- 13.1.14 TELESPECIALISTS
  - 13.1.14.1 Business overview
  - 13.1.14.2 Products/Services/Solutions offered
  - 13.1.14.3 Recent developments
    - 13.1.14.3.1 Product launches
    - 13.1.14.3.2 Deals
    - 13.1.14.3.3 Other developments
- 13.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.)
  - 13.1.15.1 Business overview
  - 13.1.15.2 Products/Services/Solutions offered
  - 13.1.15.3 Recent developments
    - 13.1.15.3.1 Product launches
    - 13.1.15.3.2 Deals
    - 13.1.15.3.3 Expansions
- 13.1.16 CAREGILITY
  - 13.1.16.1 Business overview
  - 13.1.16.2 Products/Services/Solutions offered
  - 13.1.16.3 Recent developments
    - 13.1.16.3.1 Product launches
    - 13.1.16.3.2 Deals
    - 13.1.16.3.3 Other developments
- 13.1.17 CVS HEALTH
  - 13.1.17.1 Business overview
  - 13.1.17.2 Products/Services/Solutions offered
  - 13.1.17.3 Recent developments
    - 13.1.17.3.1 Product launches
    - 13.1.17.3.2 Deals
- 13.1.18 EVERNORTH HEALTH, INC.
  - 13.1.18.1 Business overview
  - 13.1.18.2 Products/Services/Solutions offered
  - 13.1.18.3 Recent developments
    - 13.1.18.3.1 Deals
- 13.1.19 ELATION
  - 13.1.19.1 Business overview
  - 13.1.19.2 Products/Services/Solutions offered
  - 13.1.19.3 Recent developments
    - 13.1.19.3.1 Deals
- 13.1.20 IRON BOW TECHNOLOGIES
  - 13.1.20.1 Business overview
  - 13.1.20.2 Products/Services/Solutions offered
13.2 OTHER PLAYERS
- 13.2.1 TIMEDOC, INC.
- 13.2.2 CEREBRAL INC.
- 13.2.3 KINDBODY
- 13.2.4 TRANSCARENT
- 13.2.5 CARESIMPLE INC.

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

テレヘルス&遠隔医療の世界市場 (～2030年)：機能 (遠隔診察・RPM・診断&治療・分析・事務)・用途 (遠隔lCU・遠隔放射線・遠隔循環器・糖尿病)・エンドユーザー (病院・ASC・保険者)・地域別

Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030

目次

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場概要

第6章テレヘルス&遠隔医療市場：コンポーネント別

第7章テレヘルス&遠隔医療市場：機能別

第8章テレヘルス&遠隔医療市場：用途別

第9章テレヘルス&遠隔医療市場：年齢層別

第10章テレヘルス&遠隔医療市場：エンドユーザー別

第11章テレヘルス&遠隔医療市場：地域別

第12章競合情勢

第13章企業プロファイル

第14章付録

List of Tables

List of Figures

Breakdown of supply-side primary interviews by company type, designation, and region:

List of Companies Profiled in the Report:

Research Coverage:

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT

7 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION

8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION

9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP

10 TELEHEALTH & TELEMEDICINE MARKET, BY END USER

11 TELEHEALTH & TELEMEDICINE MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

テレヘルス&遠隔医療の世界市場 (～2030年)：機能 (遠隔診察・RPM・診断&治療・分析・事務)・用途 (遠隔lCU・遠隔放射線・遠隔循環器・糖尿病)・エンドユーザー (病院・ASC・保険者)・地域別

Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

第6章 テレヘルス&遠隔医療市場：コンポーネント別

第7章 テレヘルス&遠隔医療市場：機能別

第8章 テレヘルス&遠隔医療市場：用途別

第9章 テレヘルス&遠隔医療市場：年齢層別

第10章 テレヘルス&遠隔医療市場：エンドユーザー別

第11章 テレヘルス&遠隔医療市場：地域別

第12章 競合情勢

第13章 企業プロファイル

第14章 付録

List of Tables

List of Figures

Breakdown of supply-side primary interviews by company type, designation, and region:

List of Companies Profiled in the Report:

Research Coverage:

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT

7 TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION

8 TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION

9 TELEHEALTH & TELEMEDICINE MARKET, BY AGE GROUP

10 TELEHEALTH & TELEMEDICINE MARKET, BY END USER

11 TELEHEALTH & TELEMEDICINE MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場概要

第6章テレヘルス&遠隔医療市場：コンポーネント別

第7章テレヘルス&遠隔医療市場：機能別

第8章テレヘルス&遠隔医療市場：用途別

第9章テレヘルス&遠隔医療市場：年齢層別

第10章テレヘルス&遠隔医療市場：エンドユーザー別

第11章テレヘルス&遠隔医療市場：地域別

第12章競合情勢

第13章企業プロファイル

第14章付録